XML 21 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Convertible Preferred Stock
Common Stock - Voting and Nonvoting
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other comprehensive income (loss), net
Beginning balance (in shares) at Dec. 31, 2024     781,859          
Beginning balance at Dec. 31, 2024   $ 367,617 $ 1 $ 63 $ (775) $ 930,638 $ (562,310) $ 0
Beginning balance (in shares) at Dec. 31, 2024       63,219,480        
Beginning balance (in shares) at Dec. 31, 2024         (38,469)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock - warrant exercises (in shares)       5,000        
Issuance of common stock - warrant exercises   70       70    
Employee & Director stock transactions (in shares)     11,568 16,662        
Repurchases of common stock from employee stock incentive plans (in shares)         (35,648)      
Repurchases of common stock from employee stock incentive plans   (796)     $ (796)      
Cancellation of repurchased common stock from employee stock incentive plans (in shares)       (51,373)        
Cancellation of repurchased common stock from employee stock incentive plans   (1,148)       (1,148)    
Conversion of puttable common stock into non-puttable common stock (in shares)       1,150,142        
Conversion of puttable common stock into non-puttable common stock   25,694   $ 1   25,693    
Share-based compensation, net of cancellations and forfeitures   9,739       9,739    
Net income (loss)   (21,420)         (21,420)  
Ending balance (in shares) at Mar. 31, 2025     793,427          
Ending balance at Mar. 31, 2025   379,756 $ 1 $ 64 $ (1,571) 964,992 (583,730) 0
Ending balance (in shares) at Mar. 31, 2025       64,339,911        
Ending balance (in shares) at Mar. 31, 2025         (74,117)      
Beginning balance (in shares) at Dec. 31, 2024     781,859          
Beginning balance at Dec. 31, 2024   367,617 $ 1 $ 63 $ (775) 930,638 (562,310) 0
Beginning balance (in shares) at Dec. 31, 2024       63,219,480        
Beginning balance (in shares) at Dec. 31, 2024         (38,469)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 2,107              
Ending balance (in shares) at Jun. 30, 2025     793,427          
Ending balance at Jun. 30, 2025   418,266 $ 1 $ 60 $ (1,571) 978,856 (560,203) 1,123
Ending balance (in shares) at Jun. 30, 2025       60,339,083        
Ending balance (in shares) at Jun. 30, 2025         (74,117)      
Beginning balance (in shares) at Mar. 31, 2025     793,427          
Beginning balance at Mar. 31, 2025   379,756 $ 1 $ 64 $ (1,571) 964,992 (583,730) 0
Beginning balance (in shares) at Mar. 31, 2025       64,339,911        
Beginning balance (in shares) at Mar. 31, 2025         (74,117)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock reacquired in exchange for pre-funded warrant (in shares)       (6,218,504)        
Common stock reacquired in exchange for pre-funded warrant 0     $ (6)   6    
Issuance of common stock - warrant exercises (in shares)       1,540,280        
Issuance of common stock - warrant exercises   3,237   $ 2   3,235    
Employee & Director stock transactions (in shares)       281,505        
Employee & Director stock transactions   1,002       1,002    
Share-based compensation, net of cancellations and forfeitures (in shares)       395,891        
Share-based compensation, net of cancellations and forfeitures   9,621       9,621    
Net income (loss) 23,527 23,527         23,527  
Other comprehensive income $ 1,123             1,123
Ending balance (in shares) at Jun. 30, 2025     793,427          
Ending balance at Jun. 30, 2025   418,266 $ 1 $ 60 $ (1,571) 978,856 (560,203) 1,123
Ending balance (in shares) at Jun. 30, 2025       60,339,083        
Ending balance (in shares) at Jun. 30, 2025         (74,117)      
Beginning balance (in shares) at Dec. 31, 2025 0   0          
Beginning balance at Dec. 31, 2025 $ 881,017 881,017 $ 0 $ 86 $ (8,232) 1,522,143 (632,339) (641)
Beginning balance (in shares) at Dec. 31, 2025 85,890,086     85,890,086        
Beginning balance (in shares) at Dec. 31, 2025 (353,799)       (353,799)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock - warrant exercises (in shares)       7,600,052        
Issuance of common stock - warrant exercises   1,187   $ 8   1,179    
Employee & Director stock transactions (in shares)       1,398,186        
Employee & Director stock transactions   19,243   $ 1   19,242    
Repurchases of common stock from employee stock incentive plans (in shares)         (157,292)      
Repurchases of common stock from employee stock incentive plans   (6,313)     $ (6,313)      
Cancellation of repurchased common stock from employee stock incentive plans (in shares)       (168,689)        
Cancellation of repurchased common stock from employee stock incentive plans   (6,972)       (6,972)    
Settlement of interest payable in common stock (in shares)       2,987        
Settlement of interest payable in common stock   61       61    
Share-based compensation, net of cancellations and forfeitures   8,831       8,831    
Net income (loss)   170,224         170,224  
Other comprehensive income $ (1,722)             (1,722)
Ending balance (in shares) at Mar. 31, 2026     0          
Ending balance at Mar. 31, 2026   1,065,556 $ 0 $ 95 $ (14,545) 1,544,484 (462,115) (2,363)
Ending balance (in shares) at Mar. 31, 2026       94,722,622        
Ending balance (in shares) at Mar. 31, 2026         (511,091)      
Beginning balance (in shares) at Dec. 31, 2025 0   0          
Beginning balance at Dec. 31, 2025 $ 881,017 881,017 $ 0 $ 86 $ (8,232) 1,522,143 (632,339) (641)
Beginning balance (in shares) at Dec. 31, 2025 85,890,086     85,890,086        
Beginning balance (in shares) at Dec. 31, 2025 (353,799)       (353,799)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 214,432              
Ending balance (in shares) at Jun. 30, 2026 0   0          
Ending balance at Jun. 30, 2026 $ 1,150,301 1,150,301 $ 0 $ 99 $ (18,296) 1,588,634 (417,907) (2,229)
Ending balance (in shares) at Jun. 30, 2026 99,213,601     99,213,601        
Ending balance (in shares) at Jun. 30, 2026 (603,041)       (603,041)      
Beginning balance (in shares) at Mar. 31, 2026     0          
Beginning balance at Mar. 31, 2026   1,065,556 $ 0 $ 95 $ (14,545) 1,544,484 (462,115) (2,363)
Beginning balance (in shares) at Mar. 31, 2026       94,722,622        
Beginning balance (in shares) at Mar. 31, 2026         (511,091)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock - warrant exercises (in shares)       1,881,554        
Issuance of common stock - warrant exercises   184   $ 1   183    
Employee & Director stock transactions (in shares)       2,609,425        
Employee & Director stock transactions   36,605   $ 3   36,602    
Repurchases of common stock from employee stock incentive plans (in shares)         (91,950)      
Repurchases of common stock from employee stock incentive plans   (3,751)     $ (3,751)      
Share-based compensation, net of cancellations and forfeitures   7,365       7,365    
Net income (loss) $ 44,208 44,208         44,208  
Other comprehensive income $ 134             134
Ending balance (in shares) at Jun. 30, 2026 0   0          
Ending balance at Jun. 30, 2026 $ 1,150,301 $ 1,150,301 $ 0 $ 99 $ (18,296) $ 1,588,634 $ (417,907) $ (2,229)
Ending balance (in shares) at Jun. 30, 2026 99,213,601     99,213,601        
Ending balance (in shares) at Jun. 30, 2026 (603,041)       (603,041)